Center-Authored Papers

Filters: Author is Graff, Julie N  [Clear All Filters]
2015
Graff JN, Thomas GV, Higano CS, Beer TM.  2015.  Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation.. Curè„us. 7(12):e426. Abstract
Aggarwal RR, Beer TM, Weinberg VK, Higano C, Taplin M-E, Ryan CJ, Lin AM, Alumkal J, Graff JN, Nordquist LT et al..  2015.  Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With . Clinical genitourinary cancer. 13(3):e191-8. Abstract
2016
Graff JN, Higano CS, Hahn NM, Taylor MH, Zhang B, Zhou X, Venkatakrishnan K, Leonard JE, Sarantopoulos J.  2016.  Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors.. Cancer. 122(16):2524-2533. Abstract
2017
Bergstrom CP, Ruffell B, Ho CMT, Higano CS, Ellis WJ, Garzotto M, Beer TM, Graff JN.  2017.  Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates.. Anti-cancer drugs. 28(1):120-126. Abstract